The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women
Abstract
Objective To describe the pattern of development of incidence of multiple sclerosis (MS) over 60 years in Denmark with age-period-cohort analyses and seasonality of birth. Methods Data on virtually all patients with onset of MS have since 1950 been prospectively recorded and kept in the Danish Multiple Sclerosis Registry with multiple sources of notification. Annualized incidence rates per 100,000 were directly standardized to the European Standard Population. Results We have registered 19,536 cases with clinical onset of confirmed MS in Denmark from 1950 to 2009. From the 1950-1959 to the 2000-2009 onset period, incidence more than doubled in women, with an increase from 5.91 (95% confidence interval [CI]: 5.60-6.24) to 12.33 (95% CI: 11.91-12.75) per 100,000 per year compared with a modest 24% increase in men from 4.52 (95% CI: 4.24-4.81) to 6.08 (95% CI: 5.79-6.38). With age at onset of 50 years and older, incidence increased with a factor 4.30 in women and 2.72 in men. The female/male sex ratio increased over time and with year of birth. Age-period-cohort analysis revealed a significant birth cohort effect in addition to the age and period effect. We found no statistically significant seasonality of births. Conclusion The incidence of MS has doubled in women, most pronounced with late onset, and has only modestly increased in men. Lifestyle changes in the female population that could include fewer childbirths, increased occurrence of obesity, and increased cigarette consu…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An analysis of data from the Danish Multiple Sclerosis Registry showed that incidence in women doubled between 1950 and 2009, whereas increases among men have been more modest.31”
From Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) · cites this paper as [31]
In the citing paper
“Environmental changes that might be contributing to the rapid change in incidence among women include the rise in obesity, increased cigarette smoking, and changes in the frequency of breastfeeding infants.31, 33”
From Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) · cites this paper as [31]
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
The Danish Civil Registration System
Pedersen, C. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,713
The Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968
RE: “ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES”
Halperin, M. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112409 · Cited by 1,546
ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES
Miettinen, O. S. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112220 · Cited by 1,322
The changing demographic pattern of multiple sclerosis epidemiology
Koch-Henriksen, N., & Sørensen, P. S. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70064-8 · Cited by 1,191
Self-citationModels for temporal variation in cancer rates. II: Age–period–cohort models
Clayton, D. G., & Schifflers, E. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060406 · Cited by 922
A Web Tool for Age–Period–Cohort Analysis of Cancer Incidence and Mortality Rates
Rosenberg, P. S., Check, D. P., & Anderson, W. F. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0300 · Cited by 825
Temporal trends in the incidence of multiple sclerosis
Alonso, Á., & Hernán, M. Á. (2008) · Neurology · doi:10.1212/01.wnl.0000316802.35974.34 · Cited by 695
Research works printed but not linked: 3
- Hyllested K. Disseminated Sclerosis in Denmark: Prevalence and Geographical Distribution [doctoral thesis]. Copenhagen: J. Jørgensen; 1956.
- Allison RS, Millar JDH. Prevalence and familial incidence of disseminated sclerosis. Ulster Med J 1954;23(suppl 2):1–92.
- 10.1111/ane.12615 · DOI
Cited by
Sorted by citations
Wallin, M. T., Culpepper, W. J., Nichols, E., Bhutta, Z. A., Gebrehiwot, T. T., Hay, S. I., Khalil, I. A., Krohn, K. J., Liang, X., Naghavi, M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30443-5 · Cited by 1,134
Epidemiology and treatment of multiple sclerosis in elderly populations
Vaughn, C. B., Jakimovski, D., Kavak, K. S., Ramanathan, M. K., Benedict, R. H. B., Zivadinov, R., & Weinstock‐Guttman, B. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0183-3 · Cited by 320
Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications
Bjornevik, K., Münz, C., Cohen, J. I., & Ascherio, A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00775-5 · Cited by 246
Uncovering sex differences of rodent microglia
Han, J., Fan, Y., Zhou, K., Blomgren, K., & Harris, R. A. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02124-z · Cited by 224
Apparent changes in the epidemiology and severity of multiple sclerosis
Koch‐Henriksen, N., & Magyari, M. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00556-y · Cited by 230
Self-citationMultiple sclerosis: emerging epidemiological trends and redefining the clinical course
Portaccio, E., Magyari, M., Havrdová, E., Ruet, A., Brochet, B., Scalfari, A., Filippo, M. D., Tur, C., Montalbán, X., & Amato, M. P. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100977 · Cited by 196
Self-citationSex differences in autoimmune disorders of the central nervous system
Gold, S. M., Willing, A., Leypoldt, F., Paul, F., & Friese, M. A. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0723-8 · Cited by 122
What Can We Learn from Sex Differences in MS?
Coyle, P. K. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11101006 · Cited by 132
The Danish Multiple Sclerosis Registry
Magyari, M., Joensen, H., Laursen, B., & Koch‐Henriksen, N. (2020) · Brain and Behavior · doi:10.1002/brb3.1921 · Cited by 101
Self-citationMagyari, M., & Sørensen, P. S. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000695 · Cited by 98
Self-citationSørensen, P. S., Sellebjerg, F. T., Hartung, H.-P., Montalbán, X., Comi, G., & Tintoré, M. (2020) · Brain · doi:10.1093/brain/awaa145 · Cited by 99
Tintore, M., Cobo-Calvo, A., Carbonell, P., Arrambide, G., Otero-Romero, S., Río, J., Tur, C., Comabella, M., Nos, C., Arévalo, M. J., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012726 · Cited by 90
Shift of multiple sclerosis onset towards older age
Prosperini, L., Lucchini, M., Ruggieri, S., Tortorella, C., Haggiag, S., Massimiliano Mirabella, A., Pozzilli, C., & Gasperini, C. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-329049 · Cited by 90
Qian, Z., Li, Y., Guan, Z., Guo, P., Zheng, K., Du, Y., Yin, S., Chen, B., Wang, H., Jiang, J., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1073278 · Cited by 93
Treatment of Women with Multiple Sclerosis Planning Pregnancy
Krysko, K. M., Bove, R. M., Dobson, R., Jokubaitis, V., & Hellwig, K. (2021) · Current Treatment Options in Neurology · doi:10.1007/s11940-021-00666-4 · Cited by 92
Multiple sclerosis incidence: A systematic review of change over time by geographical region
Lane, J., Ng, H. S., Poyser, C., Lucas, R. M., & Tremlett, H. L. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103932 · Cited by 88
The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades
Romero-Pinel, L., Bau, L., Matas, E., León, I., Muñoz‐Vendrell, A., Arroyo, P., Aumatell, C. M., Martínez-Yélamos, A., & Martínez‐Yélamos, S. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104103 · Cited by 83
Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosis
Magyari, M., & Koch‐Henriksen, N. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-328994 · Cited by 73
Self-citationThe kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria
Arrambide, G., Espejo, C., Carbonell‐Mirabent, P., Dieli-Crimi, R., Rodríguez, M., Castillo, M., Auger, C., Cárdenas‐Robledo, S., Castilló, J., Cobo‐Calvo, Á., et al. (2022) · Brain · doi:10.1093/brain/awac220 · Cited by 70
Role of environmental factors in multiple sclerosis
Zarghami, A., Li, Y., Claflin, S. B., van der Mei, I. A. F., & Taylor, B. V. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1978843 · Cited by 66
Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis
Mouresan, E. F., Mentesidou, E., Berglund, A., McKay, K. A., Hillert, J. A., & Iacobaeus, E. (2024) · Neurology · doi:10.1212/wnl.0000000000208051 · Cited by 61
Coyle, P. K., Oh, J., Magyari, M., Oreja‐Guevara, C., & Houtchens, M. K. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.04.003 · Cited by 59
Self-citationIncreasing age of multiple sclerosis onset from 1920 to 2022: a population-based study
Habbestad, A., Willumsen, J. S., Aarseth, J. H., Grytten, N., Midgard, R., Wergeland, S., Myhr, K., & Torkildsen, Ø. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12047-9 · Cited by 65
Nielsen, N. M., Corn, G., Frisch, M., Stenager, E., Koch‐Henriksen, N., Wohlfahrt, J., Magyari, M., & Melbye, M. (2019) · Brain · doi:10.1093/brain/awz088 · Cited by 53
Self-citationLassiter, G., Melancon, C., Rooney, T., Murat, A.-M., Kaye, J. S., Kaye, A. M., Kaye, R. J., Cornett, E. M., Kaye, A. D., Shah, R. J., et al. (2020) · Neurology International · doi:10.3390/neurolint12030016 · Cited by 52
Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review
Bove, R. M., Okai, A. F., Houtchens, M. K., Elias-Hamp, B., Lugaresi, A., Hellwig, K., & Havrdová, E. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.554375 · Cited by 51
Capasso, N., Virgilio, E., Covelli, A., Giovannini, B., Foschi, M., Montini, F., Nasello, M., Nilo, A., Prestipino, E., Schirò, G., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1207617 · Cited by 52
Wimberley, T., Horsdal, H. T., Brikell, I., Laursen, T. M., Astrup, A., Fanelli, G., Bralten, J., Poelmans, G., van Gils, V., Jansen, W. J., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04163-z · Cited by 46
Reproductive history of the Danish multiple sclerosis population: A register-based study
Moberg, J. Y., Laursen, B., Thygesen, L. C., & Magyari, M. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519851245 · Cited by 46
Self-citationKuchling, J., & Paul, F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00450 · Cited by 42
Knowles, S., Middleton, R., Cooze, B., Farkas, I., Leung, Y. Y., Allen, K., Winslade, M., Owen, D. R., Magliozzi, R., Reynolds, R., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26843 · Cited by 39
Simonsen, C. S., Flemmen, H. Ø., Broch, L., Brunborg, C., Berg‐Hansen, P., Moen, S. M., & Celius, E. G. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10279-7 · Cited by 39
Relapsing and progressive MS: the sex-specific perspective
Rommer, P. S., Ellenberger, D., Hellwig, K., Haas, J., Pöhlau, D., Stahmann, A., Zettl, U. K., & on behalf of the Scientific Advisory Group of the German MS-Register by the German MS Society (2020) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286420956495 · Cited by 37
Elser, H. C., Parks, R. M., Moghavem, N., Kiang, M. V., Bozinov, N., Henderson, V. W., Rehkopf, D. H., & Casey, J. A. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003580 · Cited by 40
Proteomics in Multiple Sclerosis: The Perspective of the Clinician
Sandi, D., Kokas, Z., Biernacki, T., Bencsik, K., Klivènyi, P., & Vécsei, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095162 · Cited by 38
Kaufmann, M., Puhan, M. A., Kühle, J., Yaldizli, Ö., Magnusson, T., Kamm, C. P., Calabrese, P., & von Wyl, V. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00953 · Cited by 35
Gbaguidi, B., Guillemin, F., Soudant, M., Debouverie, M., Mathey, G., & Epstein, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-04836-5 · Cited by 38
Miclea, A., Salmen, A., Zoehner, G., Diem, L., Kamm, C. P., Chaloulos‐Iakovidis, P., Miclea, M., Briner, M., Kilidireas, K., Stefanis, L., et al. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13083 · Cited by 33
Pregnancy-Related and Perinatal Outcomes in Women With Multiple Sclerosis
Andersen, J. B., Kopp, T. I., Sellebjerg, F. T., & Magyari, M. (2021) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001035 · Cited by 32
Self-citationKearns, P. K. A., Paton, M., O’Neill, M., Waters, C., Colville, S., McDonald, J. J., Young, I. J. B., Pugh, D., O’Riordan, J. I., Weller, B., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09413-x · Cited by 31
Epidemiology of multiple sclerosis in Central Europe, update from Hungary
Biernacki, T., Sandi, D., Fricska‐Nagy, Z., Kincses, Z. T., Füvesi, J., Laczkó, R., Kokas, Z., Klivènyi, P., Vécsei, L., & Bencsik, K. (2020) · Brain and Behavior · doi:10.1002/brb3.1598 · Cited by 32
Late-onset MS is associated with an increased rate of reaching disability milestones
Andersen, M. A., Buron, M. D., & Magyari, M. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10490-0 · Cited by 31
Self-citationKee, R., Naughton, M., McDonnell, G. V., Howell, O. W., & Fitzgerald, D. C. (2022) · Biomedicines · doi:10.3390/biomedicines10102604 · Cited by 34
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review
Fernández, Ó., Sørensen, P. S., Comı, G., Vermersch, P., Hartung, H., Leocani, L., Berger, T., Wijmeersch, B. V., & Oreja‐Guevara, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1379538 · Cited by 30
Rubin, K. H., Rasmussen, N. F., Petersen, I., Kopp, T. I., Stenager, E., Magyari, M., Hetland, M. L., Bygum, A., Glintborg, B., & Andersen, V. C. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.49314 · Cited by 28
Self-citationSiblings reduce multiple sclerosis risk by preventing delayed primary Epstein–Barr virus infection
Rostgaard, K., Nielsen, N. M., Melbye, M., Frisch, M., & Hjalgrim, H. (2022) · Brain · doi:10.1093/brain/awac401 · Cited by 27
Melamed, E., Palmer, J. L., & Fonken, C. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1019877 · Cited by 26
Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis
Tobore, T. O. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1677648 · Cited by 31
Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence
Holm, R. P., Wandall‐Holm, M. F., & Magyari, M. (2024) · Brain · doi:10.1093/brain/awae245 · Cited by 26
Self-citationLate onset multiple sclerosis is associated with more severe ventricle expansion
Jakimovski, D., Dujmić, D., Hagemeier, J., Ramasamy, D. P., Bergsland, N., Dwyer, M. G., Eckert, S. P., Kolb, C., Lizarraga, A., Hojnacki, D. W., et al. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102588 · Cited by 27
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy
Rossi, C., Cicalini, I., Zucchelli, M., di Ioia, M., ONOFRJ, M. C., Federici, L., Boccio, P. D., & Pieragostino, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113589 · Cited by 25
Clinical outcomes in multifocal motor neuropathy
Herraets, I. J. T., van Rosmalen, M., Bos, J. W., van Eijk, R. P. A., Cats, E., Jongbloed, B. A., Vlam, L., Piepers, S., Asseldonk, J.-T. V., Goedee, H. S., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010538 · Cited by 25
The prevalence and incidence of multiple sclerosis over the past 20 years in northern Japan
Houzen, H., Kano, T., Kondo, K., Takahashi, T., & Niino, M. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104696 · Cited by 25
Differential Diagnosis of Suspected Multiple Sclerosis in Pediatric and Late-Onset Populations
Hua, L. H., Solomon, A. J., Tenembaum, S. N., Scalfari, A., Rovira, À., Rostasy, K. M., Newsome, S. D., Marrie, R. A., Magyari, M., Kantarci, O. H., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.3062 · Cited by 23
Self-citationAndersen, J. B., Wandall‐Holm, M. F., & Magyari, M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103529 · Cited by 22
Self-citationBarzegar, M., Vaheb, S., Mirmosayyeb, O., Ashtari, F., Afshari-Safavi, A., Adibi, I., Shaygannejad, A., Mazaheri, S., Rahimi, M., & Shaygannejad, V. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105479 · Cited by 22
Simpson, S., Atvars, R., Blizzard, L., van der Mei, I. A. F., & Taylor, B. V. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-328932 · Cited by 21
Changes in prognosis of the Danish multiple sclerosis population over time
Magyari, M., Joensen, H., Kopp, T. I., Pontieri, L., & Koch‐Henriksen, N. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585221110582 · Cited by 21
Self-citationLorefice, L., Ferraro, O. E., Fenu, G., Amato, M. P., Morra, V. B., Conte, A., Luca, G. D., Ferraro, D., Filippi, M., Gazzola, P., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-023-12152-9 · Cited by 22
Prevalence of multiple sclerosis in rural and urban districts in Telemark county, Norway
Flemmen, H. Ø., Simonsen, C. S., Berg‐Hansen, P., Moen, S. M., Kersten, H., Heldal, K., & Celius, E. G. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102352 · Cited by 22
Age and sex as determinants of treatment decisions in patients with relapsing-remitting MS
Sørensen, P. S., Kopp, T. I., Joensen, H., Olsson, A., Sellebjerg, F. T., & Magyari, M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102813 · Cited by 20
Self-citationTraditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis
Gado, F., Digiacomo, M., Macchia, M., Bertini, S., & Manera, C. (2018) · Medicines · doi:10.3390/medicines5030091 · Cited by 21
Immunosenescence: the role of age in multiple sclerosis
Ibáñez, A. O., Laviñeta, J. C., & Blanco, T. A. (2022) · Neurología (English Edition) · doi:10.1016/j.nrleng.2020.05.023 · Cited by 20
Trends in the environmental risks associated with earlier onset in multiple sclerosis
Huang, J., Kockum, I. S., & Stridh, P. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104250 · Cited by 20
Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives
Lorefice, L., D’Alterio, M. N., Firinu, D., Fenu, G., & Cocco, E. E. (2023) · International Journal of Women s Health · doi:10.2147/ijwh.s334719 · Cited by 19
Lorefice, L., Fenu, G., Fronza, M., Murgia, F., Frau, J., Coghe, G., Barracciu, M. A., Atzori, L., Angioni, S. L., & Cocco, E. E. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1251667 · Cited by 19
Geochemistry of multiple sclerosis in Finland
Åström, M., & Roos, P. M. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156672 · Cited by 18
Changes in multiple sclerosis epidemiology in Finland over five decades
Pirttisalo, A., Soilu‐Hänninen, M., Sumelahti, M., Krökki, O., Murtonen, A., Hänninen, K., & Sipilä, J. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13295 · Cited by 23
Iljicsov, A., Milanovich, D., Ajtay, A., Oberfrank, F., Bálint, M., Dobi, B., Bereczki, D., & Simó, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236432 · Cited by 20
Inmunosenescencia: el rol de la edad en la esclerosis múltiple
Ostolaza, A., Laviñeta, J. C., & Blanco, T. A. (2020) · Neurología · doi:10.1016/j.nrl.2020.05.016 · Cited by 17
Challenges in Diagnosis and Therapeutic Strategies in Late-Onset Multiple Sclerosis
Nociti, V., Romozzi, M., & Massimiliano Mirabella, A. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14040400 · Cited by 17
Diet quality is not associated with late-onset multiple sclerosis risk– A Danish Cohort Study
Pommerich, U. M., Nielsen, R. O., Overvad, K., Dahm, C. C., Tjønneland, A. M., Olsen, A., & Dalgas, U. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.101968 · Cited by 16
Marstrand, L., Østerberg, O., Walsted, T., Skov, A. C., Schreiber, K. I., & Sellebjerg, F. T. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101458 · Cited by 16
The influence of menopause on multiple sclerosis
Simonsen, C. S., Flemmen, H. Ø., Broch, L., Myklebust, H., Berg‐Hansen, P., Brunborg, C., & Celius, E. G. (2024) · European Journal of Neurology · doi:10.1111/ene.16566 · Cited by 15
Incidence and prevalence of multiple sclerosis in Spain: a systematic review
López, F. J. G., Garcı́a-Merino, A., Alcalde-Cabero, E., & de Pedro‐Cuesta, J. (2022) · Neurología (English Edition) · doi:10.1016/j.nrleng.2022.02.004 · Cited by 17
Multiple Sclerosis and Other Acquired Demyelinating Diseases of the Central Nervous SystemPreprint
Kornberg, M. D., & Calabresi, P. A. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041374 · Cited by 17
Incidencia y prevalencia de la esclerosis múltiple en España. Una revisión sistemática
López, F. J. G., Garcı́a-Merino, A., Alcalde-Cabero, E., & de Pedro-Cuesta, J. (2022) · Neurología · doi:10.1016/j.nrl.2022.02.006 · Cited by 21
Clinical Management in Multiple Sclerosis
Arredondo-Robles, A. V., Rodriguez-Lopez, K., & Ávila‐Avilés, R. D. (2025) · Neuroglia · doi:10.3390/neuroglia6010006 · Cited by 15
Epidemiology of neuromyelitis optica spectrum disorder in Denmark (1998–2008, 2007–2014)
Asgari, N., Lillevang, S. T., Skejø, H. P. B., & Kyvik, K. O. (2019) · Brain and Behavior · doi:10.1002/brb3.1338 · Cited by 14
Cannabinoid-Based Medicines and Multiple Sclerosis
Manera, C., & Bertini, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_8 · Cited by 15
Hjæresen, S., Sejbæk, T., Axelsson, M., Mortensen, S. K., Vinsløv-Jensen, H., Pihl-Jensen, G., Novakova, L., Pedersen, C. B., Halle, B., Poulsen, F. R., et al. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120320 · Cited by 14
Neurological Disorders following COVID-19 Vaccination
Yang, Y. L., & Huang, L. (2023) · Vaccines · doi:10.3390/vaccines11061114 · Cited by 14
Aging With Multiple Sclerosis: Age-Related Factors and Socioeconomic Risks
Wandall‐Holm, M. F., Andersen, M. A., Buron, M. D., & Magyari, M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.818652 · Cited by 14
Self-citationMultiple sclerosis prevalence in 2000 and 2010 in Western Finland
Murtonen, A., & Sumelahti, M. (2019) · Acta Neurologica Scandinavica · doi:10.1111/ane.13203 · Cited by 13
The MSBase pregnancy, neonatal outcomes, and women’s health registry
Jokubaitis, V., Skibina, O. G., Alroughani, R., Altıntaş, A., Butzkueven, H., Eichau, S., Fragoso, Y. D., Hellwig, K., Hughes, S. E., Rath, L., et al. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211009104 · Cited by 12
Comorbidity in the aging population with multiple sclerosis: a Danish nationwide study
Holm, R. P., Wandall‐Holm, M. F., Sellebjerg, F. T., & Magyari, M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1297709 · Cited by 11
Self-citationAs time goes by: Treatment challenges in elderly people with multiple sclerosis
Gelibter, S., Saraceno, L., Pirro, F., Susani, E. L., & Protti, A. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578368 · Cited by 13
Maunula, A., Laakso, S. M., Viitala, M., Soilu‐Hänninen, M., Sumelahti, M., & Atula, S. (2025) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/20552173251326173 · Cited by 12
Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection
Samara, A., Cantoni, C., Piccio, L. M., Cross, A. H., & Chahin, S. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104768 · Cited by 10
Women and multiple sclerosis: From gender medicine to precision medicine
Lorefice, L., & Lugaresi, A. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106348 · Cited by 9
Barbuti, E., Piervincenzi, C., Ruggieri, S., & Petracca, M. (2025) · Brain Sciences · doi:10.3390/brainsci15101097 · Cited by 9
Moghtaderi, A., Shahidi-Pourakbari, M., Izadi, S., Khosravi, A., & Hashemzehi, Z. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104557 · Cited by 9
MENG, Q., Cui, E., Leroux, A., Mowry, E. M., Lindquist, M. A., & Crainiceanu, C. M. (2023) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003260 · Cited by 9
Chow, H. H., Petersen, E. R., Olsson, A., Laursen, J. H., Hansen, M. B., Oturai, A. B., Sørensen, P. S., Søndergaard, H. B., & Sellebjerg, F. T. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105701 · Cited by 9
Stable excess mortality in a multiple sclerosis cohort diagnosed 1970–2010
Sumelahti, M., Verkko, A., Kytö, V., & Sipilä, J. (2024) · European Journal of Neurology · doi:10.1111/ene.16480 · Cited by 9
Pharmacoeconomics of synthetic therapies for multiple sclerosis
D’Amico, E., Chisari, C. G., Gitto, L., Zanghì, A., Toscano, S., & Patti, F. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1615880 · Cited by 9
Late onset multiple sclerosis — multiparametric MRI characteristics
Jasek, Ł., Śmigielski, J., & Siger, M. (2020) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2020.0036 · Cited by 9
Seasonal patterns of relapse and disability in Danish MS patients: A population-based cohort study
Elser, H. C., Koch‐Henriksen, N., & Magyari, M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102739 · Cited by 10
Self-citationAge-Related Disability Outcomes After a First Demyelinating Event
Cobo‐Calvo, Á., Carbonell‐Mirabent, P., Tur, C., Otero‐Romero, S., Carvajal, R., Arrambide, G., Ariño, H., Auger, C., Villacieros‐Álvarez, J., Bollo, L., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000210305 · Cited by 8
The Effects of Neuroactive Steroids on Myelin in Health and Disease
Kalakh, S., & Mouihate, A. (2024) · Medical Principles and Practice · doi:10.1159/000537794 · Cited by 8
Metadata
- Authors
- Koch-Henriksen, N., Thygesen, L. C., Stenager, E., Laursen, B., & Magyari, M.
- Affiliations
- From the Clinical Institute (N.K.-H.), Department of Clinical Epidemiology, University of Aarhus; Danish Multiple Sclerosis Registry (N.K.-H., E.S., M.M.) and Department of Neurology (M.M.), Rigshospitalet, University of Copenhagen; National Institute of Public Health (L.C.T., B.L.), University of Southern Denmark in Copenhagen; Institute of Regional Health Research (E.S.), University of Southern Denmark, Odense.
- University of Copenhagen (DK)
- Venue
- Neurology
- Published
- 2018-05-29
- Volume
- 90
- Issue
- 22
- Pages
- e1954-e1963
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2799594477
- Cited by
- 188
- References
- 45
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 23 · 2023: 25 · 2022: 27 · 2021: 19 · 2020: 21 · 2019: 25 · 2018: 6
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Climate Change and Health Impacts
- Keywords
- multiple sclerosis, incidence trends, sex differences, late-onset multiple sclerosis, birth cohort effects, birth seasonality, age-period-cohort analysis, lifestyle factors, Denmark
- MeSH terms
- Adult, Denmark, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Prospective Studies, Registries, Sex Factors, Incidence, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review